tetano
Editor, Senior Moderator
HIV Med
. 2020 Jul 15.
doi: 10.1111/hiv.12911. Online ahead of print.
Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review
T J Cooper[SUP] 1 [/SUP], B L Woodward[SUP] 1 [/SUP], S Alom[SUP] 2 [/SUP], A Harky[SUP] 3 4 [/SUP]
Affiliations
Abstract
Objectives: The aim of the study was to systematically review current studies reporting on clinical outcomes in people living with HIV (PLHIV) infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Methods: We conducted a systematic review using the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. A comprehensive literature search was conducted in Global Health, SCOPUS, Medline and EMBASE using pertinent key words and Medical Subject Headings (MeSH) terms relating to coronavirus disease 2019 (COVID-19) and HIV. A narrative synthesis was undertaken. Articles are summarized in relevant sections.
Results: Two hundred and eighty-five articles were identified after duplicates had been removed. After screening, eight studies were analysed, totalling 70 HIV-infected patients (57 without AIDS and 13 with AIDS). Three themes were identified: (1) controlled HIV infection does not appear to result in poorer COVID-19 outcomes, (2) more data are needed to determine COVID-19 outcomes in patients with AIDS and (3) HIV-infected patients presenting with COVID-19 symptoms should be investigated for superinfections.
Conclusions: Our findings suggest that PLHIV with well-controlled disease are not at risk of poorer COVID-19 disease outcomes than the general population. It is not clear whether those with poorly controlled HIV disease and AIDS have poorer outcomes. Superimposed bacterial pneumonia may be a risk factor for more severe COVID-19 but further research is urgently needed to elucidate whether PLHIV are more at risk than the general population.
Keywords: AIDS; HIV; coronavirus disease 2019; severe acute respiratory syndrome coronavirus.
. 2020 Jul 15.
doi: 10.1111/hiv.12911. Online ahead of print.
Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review
T J Cooper[SUP] 1 [/SUP], B L Woodward[SUP] 1 [/SUP], S Alom[SUP] 2 [/SUP], A Harky[SUP] 3 4 [/SUP]
Affiliations
- PMID: 32671970
- DOI: 10.1111/hiv.12911
Abstract
Objectives: The aim of the study was to systematically review current studies reporting on clinical outcomes in people living with HIV (PLHIV) infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Methods: We conducted a systematic review using the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. A comprehensive literature search was conducted in Global Health, SCOPUS, Medline and EMBASE using pertinent key words and Medical Subject Headings (MeSH) terms relating to coronavirus disease 2019 (COVID-19) and HIV. A narrative synthesis was undertaken. Articles are summarized in relevant sections.
Results: Two hundred and eighty-five articles were identified after duplicates had been removed. After screening, eight studies were analysed, totalling 70 HIV-infected patients (57 without AIDS and 13 with AIDS). Three themes were identified: (1) controlled HIV infection does not appear to result in poorer COVID-19 outcomes, (2) more data are needed to determine COVID-19 outcomes in patients with AIDS and (3) HIV-infected patients presenting with COVID-19 symptoms should be investigated for superinfections.
Conclusions: Our findings suggest that PLHIV with well-controlled disease are not at risk of poorer COVID-19 disease outcomes than the general population. It is not clear whether those with poorly controlled HIV disease and AIDS have poorer outcomes. Superimposed bacterial pneumonia may be a risk factor for more severe COVID-19 but further research is urgently needed to elucidate whether PLHIV are more at risk than the general population.
Keywords: AIDS; HIV; coronavirus disease 2019; severe acute respiratory syndrome coronavirus.